Navigation Links
AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured
Date:7/16/2009

WILMINGTON, Del., July 16 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that it will provide free medication to eligible patients through Primary Health Care in Des Moines, under one of the company's prescription savings programs.

The AZ&Me(TM) Prescription Savings program for healthcare facilities provides medicines free of charge to community free clinics, community health centers, hospitals and other qualifying facilities that serve patients without prescription drug coverage. This enables patients to quickly get the medicines they need, often at the same place they receive their medical care.

"AstraZeneca believes it is important to help those who need our medicines," said Jennifer McGovern, Director, Patient Assistance Programs, AstraZeneca Pharmaceuticals LP. "We understand that our medicines don't do patients any good if they cannot access them."

In 2008, AstraZeneca provided $8.6 million in savings to more than 5,400 patients in Iowa. Nationally, the company helped more than 440,000 patients save $612 million on their medicines.

Primary Health Care is a nonprofit community health center dedicated to providing healthcare and supportive services for people in Central Iowa to improve their quality of life. In 2008, Primary Health Care served nearly 22,300 patients by providing more than 70,000 medical, dental and mental health visits to residents of Polk and Marshall Counties. Of those served by Primary Health Care, 55 percent are uninsured.

"At Primary Health Care, we believe that everyone is entitled to quality health care regardless of their financial status," said Kelly Huntsman, Executive Director, Primary Health Care. "Through our collaboration with AstraZeneca, we will be able to provide solutions for the uninsured in Iowa, creating accessibility to medications that are critical to their health."

The AZ&Me Prescription Savings program for healthcare facilities is available to non-profit organizations that have a licensed outpatient pharmacy or dispensary on site and meet other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and have a household income at or below $30,000 for an individual, or $60,000 for a family of four.

With this program, AstraZeneca builds on its more than 30-year history of helping patients afford the medicines they need.

To learn if your organization qualifies for the AZ&Me Prescription Savings program for healthcare facilities, please call 1-866-325-8198. Program specialists are available Monday through Friday between the hours of 9:00 AM and 5:00 PM ET.

Prescription savings programs are available regardless of which medications your doctors prescribe. To find out more about the more than 475 savings programs covering 2,500 medications, please visit www.pparx.org or call 1-888-4ppa-now (1-888-477-2669).

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: www.astrazeneca-us.com.

About Primary Health Care, Inc. (PHC)

PHC has been providing medical, dental and support services to the underserved since 1981. PHC offers a full spectrum of medical and dental services, including family practice, adult medicine, pediatrics, OB, mental health, oral medicine, pharmacy, lab and x-ray. Each clinic provides preventive services, such as immunizations and screenings. PHC specializes in caring for the underserved and homeless.

The timeline of steady growth for PHC includes: 1988-Health Care for the Homeless; 1991-Ryan White HIV care; 1998-Maternal Child Programs in partnership with the State of Iowa and later Healthy Start; 2000-Housing Advocacy via HUD (Housing and Urban Development) funding; 2001-new site in Marshalltown; 2002-Relocation from Broadlawns Medical Center to 2353 SE 14th Street; 2003-East Side Clinic; 2004-Community Access Pharmacy; 2005-new dental unit in Marshalltown; 2007-Des Moines dental clinic expansion, and both East Side and South Side service expansions. Our premiere project for 2008-2009 is the relocation of the Outreach Clinic. For more information about PHC, please visit www.phcinc.net


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease
2. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
3. Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
4. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
5. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
6. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
7. AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities
8. AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
9. Ingenuity Systems Announces Multi-Year Deal With AstraZeneca
10. Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT RESPULES Patent Litigation
11. FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... CA (PRWEB) , ... February 13, 2016 , ... With ... particle overlays to footage all within Final Cut Pro X. Each user can select ... over 3D rotation, angle of view, blur, focus offset, hue, saturation, value, contrast, glow, ...
(Date:2/13/2016)... Salt Lake City, Utah (PRWEB) , ... February 13, 2016 , ... When an ... kids, Host Parents aren’t always sure what they are in for and they are often ... Pairs are more than they were hoping for. This year’s Au Pair of the Year ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s Day tips ... biography of Rama - Dr. Frederick Lenz. , According to Publisher Roger ... Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love in all ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut water ... LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s ... big event. The invitation-only gifting suite, held this year at the W Hollywood Hotel, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... 11, 2016 The primary goal of this ... patterns on the usage of liquid biopsy. Key information ... - Timeframe of liquid biopsy adoption amidst future ... Evs—by organization type - Sample inflow to conduct liquid ... stool, serum, and so on. - Correlation analysis of ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, today announced the ... the New Animal Drug Application (NADA) for Zimeta™ (dipyrone ... study (KB0120) of Zimeta for the control of pyrexia ... --> --> The ...
Breaking Medicine Technology: